<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01045733</url>
  </required_header>
  <id_info>
    <org_study_id>M-09-045</org_study_id>
    <nct_id>NCT01045733</nct_id>
  </id_info>
  <brief_title>A Comparison of Corneal Aberrations in Subjects With Contralateral AcrySof IQ Toric Intraocular Lens (IOL) and AcrySof IQ IOL With Limbal Relaxing Incision (LRI)</brief_title>
  <official_title>A Prospective Contralateral Comparison of Corneal Aberrations in Subjects Undergoing Aspheric Lens Implantation With Concomitant LRI and Aspheric Toric IOL Implantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to evaluate and compare postoperative corneal aberrations and
      visual parameters in patients contralaterally implanted with an AcrySof IQ Toric intraocular
      lens (IOL) and AcrySof IQ Aspheric IOL with concomitant limbal relaxing incision.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2009</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">May 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Corneal Aberration</measure>
    <time_frame>Month 6 postoperative</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Acuity</measure>
    <time_frame>Month 6 postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corneal Cylinder</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Cataract</condition>
  <condition>Astigmatism</condition>
  <arm_group>
    <arm_group_label>IQ Toric IOL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>AcrySof IQ Toric intraocular lens (IOL) randomly assigned to one eye, with AcrySof IQ Aspheric IOL with Limbal Relaxing Incision (LRI) procedure in the fellow eye for contralateral implantation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IQ Aspheric IOL + LRI</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>AcrySof IQ Aspheric intraocular lens (IOL) with Limbal Relaxing Incision (LRI) procedure randomly assigned to one eye, with AcrySof IQ Toric IOL in the fellow eye for contralateral implantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AcrySof IQ Toric IOL</intervention_name>
    <description>AcrySof IQ Toric intraocular lens implanted in the capsular bag of the eye during cataract surgery. The IOL is intended for the lifetime of the patient.</description>
    <arm_group_label>IQ Toric IOL</arm_group_label>
    <other_name>AcrySof IQ Toric IOL Model SN6AT3</other_name>
    <other_name>AcrySof IQ Toric IOL Model SN6AT4</other_name>
    <other_name>AcrySof IQ Toric IOL Model SN6AT5</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AcrySof IQ Aspheric IOL</intervention_name>
    <description>AcrySof IQ aspheric intraocular lens implanted in the capsular bag of the eye during cataract surgery. The IOL is intended for the lifetime of the patient.</description>
    <arm_group_label>IQ Aspheric IOL + LRI</arm_group_label>
    <other_name>AcrySof IQ Aspheric IOL Model SN60WF</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Limbal Relaxing Incision (LRI)</intervention_name>
    <description>An incision was made at the corneal-limbal junction during cataract surgery for the purpose of relaxing corneal curvature, ie., correcting astigmatism.</description>
    <arm_group_label>IQ Aspheric IOL + LRI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Ocular criteria must be met in both eyes.

          -  Willing and able to understand and sign an informed consent;

          -  Willing and able to attend postoperative examinations per protocol schedule;

          -  Have cataracts that require extraction followed by implantation of a posterior chamber
             intraocular lens and used as an on-label procedure;

          -  Free of disease(s)/condition(s) listed in the &quot;Caution&quot; section of the AcrySof IQ and
             AcrySof IQ Toric package inserts;

          -  Have regular, bowtie shaped corneal astigmatism and qualify for an SN6AT3, SN6AT4 or
             SN6AT5 Intraocular Lens (IOL) in both eyes;

          -  Have the second surgery at least one week following the first eye implant but not
             later than one month after the first implant.

          -  Other protocol-defined inclusion criteria may apply.

        Exclusion Criteria:

          -  Previous corneal surgery;

          -  Planned multiple procedures during cataract/IOL implantation surgery;

          -  Ocular disease and/or condition that may compromise study results;

          -  Pregnant or planning pregnancy during course of study;

          -  Other protocol-defined exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Contact Alcon Call Center for Trial Locations</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 8, 2010</study_first_submitted>
  <study_first_submitted_qc>January 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 11, 2010</study_first_posted>
  <last_update_submitted>November 27, 2012</last_update_submitted>
  <last_update_submitted_qc>November 27, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 29, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cataract</keyword>
  <keyword>Toric</keyword>
  <keyword>IOL</keyword>
  <keyword>AcrySof</keyword>
  <keyword>LRI</keyword>
  <keyword>Astigmatism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Astigmatism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

